Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640334-23-000532
Filing Date
2023-03-31
Accepted
2023-03-31 15:51:19
Documents
62
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K bdpt_10k.htm   iXBRL 10-K 806975
2 ARTICLES bdpt_ex31.htm EX-3.1 648
3 CERTIFICATION bdpt_ex311.htm EX-31.1 11668
4 CERTIFICATION bdpt_ex312.htm EX-31.1 9558
5 CERTIFICATION bdpt_ex321.htm EX-32.1 5047
6 CERTIFICATION bdpt_ex322.htm EX-32.2 5020
12 bdpt_ex31img3.jpg GRAPHIC 105426
13 bdpt_10kimg11.jpg GRAPHIC 6820
  Complete submission text file 0001640334-23-000532.txt   3945326

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA bdpt-20221231.xsd EX-101.SCH 37827
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdpt-20221231_lab.xml EX-101.LAB 228615
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdpt-20221231_cal.xml EX-101.CAL 37955
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdpt-20221231_pre.xml EX-101.PRE 193201
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdpt-20221231_def.xml EX-101.DEF 109700
56 EXTRACTED XBRL INSTANCE DOCUMENT bdpt_10k_htm.xml XML 512629
Mailing Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128 (702) 659-8829
BIOADAPTIVES, INC. (Filer) CIK: 0001575142 (see all company filings)

EIN.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54949 | Film No.: 23787264
SIC: 2834 Pharmaceutical Preparations